Fund profile · Compiled from public sources

Biovance Capital

Lisbon, Portugal · Seed → Series A

Their stated focus (public profile)

Biovance Capital is a biotech-focused early-stage fund investing in seed and Series A rounds in biopharma companies across Europe, with a focus on Southern European countries. The fund backs therapeutics companies across any modality and therapeutic area, requiring robust preclinical models and patented or patentable assets. It works closely with entrepreneurs to build leading companies and typically co-invests with additional investors to add value and mitigate risk.

Stages: Seed → Series A

Sectors: Life sciences

Website: biovancecapital.com

This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.

Is this your fund? Request a correction or removal.

For founders · Find a fund

Search the funds we have on file

Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.

    Looking to claim your own fund? Start here →